Skip to main content
JEONJINBIO CO., LTD. logo

JEONJINBIO CO., LTD. — Investor Relations & Filings

Ticker · 110020 ISIN · KR7110020005 KO Manufacturing
Open in API
Filings indexed 370 across all filing types
Latest filing 2026-03-24 Declaration of Voting R…
Country KR South Korea
Listing KO 110020

About JEONJINBIO CO., LTD.

http://jjbious.com/01

JEONJINBIO CO., LTD. is a biotechnology company specializing in the research, development, and production of products for pest control and the mitigation of damage from nuisance animals. The company's core offerings consist of natural bio-pesticides and repellents formulated from natural materials as alternatives to conventional chemical products. Its product line includes specialized solutions for repelling birds, boars, and other animals. The company emphasizes innovation and safety, supported by its dedicated research and development center and various product certifications, including USA EPA approval for its bird repellent.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled “정기주주총회결과” (Regular Shareholders’ Meeting Results) and provides detailed vote outcomes for each agenda item, percentages of votes in favor, and other shareholder meeting particulars. It is not an annual report or meeting materials but specifically the formal announcement of voting results from an AGM. Therefore, it matches the Declaration of Voting Results & Voting Rights Announcements category (DVA).
2026-03-24 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report' (감사보고서) for Jeonjin BioPharm Co., Ltd. for the fiscal year ending December 31, 2025. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. It is a comprehensive financial document, not an announcement or a summary, and fits the definition of an Audit Report/Information (AR) as it contains the audit opinion and financial statements. FY 2025
2026-03-16 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) system titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of the audit opinion, key financial data (assets, liabilities, revenue, profit/loss), and auditor information for the fiscal year 2025. While it contains financial data, it is a standard regulatory disclosure form used to announce the receipt and filing of the audit report, rather than the full audit report document itself. According to the 'Menu vs Meal' rule, this is a regulatory filing announcement. FY 2025
2026-03-16 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used to solicit shareholder votes for an upcoming General Meeting. It contains details about the meeting agenda, including financial statement approval, director/auditor compensation limits, and articles of incorporation amendments. This falls under the category of Proxy Solicitation & Information Statement.
2026-03-09 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Jeonjin Biopharm. It details the date, location, agenda items (such as financial statement approval, director/auditor re-elections, and articles of incorporation changes), and provides biographical details for the nominees. This document serves as the official proxy solicitation and information statement provided to shareholders prior to the meeting to inform their voting decisions.
2026-03-09 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Jeonjin Bio-Pharm. It contains the agenda for the upcoming Annual General Meeting (AGM), including items such as the approval of financial statements, director/auditor remuneration, and board appointments. While it contains financial data, this is provided as 'Management Reference Material' (경영참고사항) specifically for the purpose of the shareholder meeting. According to the filing definitions, materials shared for the AGM are classified as AGM-R.
2026-03-09 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.